SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Dov Pharmaceutical, Inc - DOVP
An SI Board Since April 2002
Posts SubjectMarks Bans Symbol
172 28 0 DOVP
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
147And at $1.5 B, that is $550 MM. Close to my $600 MM estimate. Still too much rRobohogs-4/25/2006
146<pre> 3.5% royalty on sales for the term of Indiplon patents issued 2002. keokalani'nui-4/25/2006
145Jefferies analyst Eun Yang nailed it. This is from just a few days ago. DOV Pharkrw-4/25/2006
144>>investors could get the pipeline “for free.”<< They might be happnigel bates-4/25/2006
143Merrill, looks like they were caught with a buy rating hanging out there. Dov Ptom pope-4/25/2006
142Would have to rank nbix taking indiplon from dov and flipping it to pfe as one orkrw-4/25/2006
141dovp royalties were one of the few where it was fully disclosed. So I can remembrkrw-4/25/2006
140Somehow, the top of your head seems to retain more information than mine. Internigel bates-4/25/2006
139I remember seeing estimates of 6% - that must be why. Sleep competitor SEPR jusRobohogs-4/25/2006
138Top of my head, the royalty rate is 3.5% but moves up to 6% in about 5 years. rkrw-4/25/2006
137Sell the royalty - that would necessarily not be good. :-)nigel bates-4/25/2006
136It would seem that as long as the money is not burned senselessly, that a multipRobohogs-4/25/2006
135Seems that Wilder just did ? (edit) Say a billion on sales in three or four yenigel bates-4/25/2006
134Has anyone done a valuation on indi royalty alone? I must admit to this news deRobohogs-4/25/2006
133Has anyone done a valuation on indi royalty alone? I must admit to this news deRobohogs-4/25/2006
132>>avoided a train wreck for once<< Me too: I'm grateful for thenigel bates-4/25/2006
131Hey. I avoided a train wreck for once. The company is worth only the Indiplon keokalani'nui-4/24/2006
130>>Don't like the way bicifadine is shaping up<< Nice call. Whnigel bates-4/24/2006
129DOV Pharmaceutical, Inc. Announces Fourth Quarter and 2005 Year-End Results and nigel bates-3/8/2006
128After a complete review of the PA, I have dumped what's left of dovp. (Don&keokalani'nui-12/16/2005
127Bunionectomy is painful operation. <i>DOV Pharmaceutical, Inc. Announcekeokalani'nui-9/12/2005
126Citigroup Investment Research DOVP: FLASH NOTE: Ocinaplon Disappointment Largelymopgcw-9/12/2005
125This will hurt tomorrow. I'll miss the cc (if anyone cares to mention anythkeokalani'nui-8/25/2005
124SSB: DOVP: Earnings Uneventful, Triple Reuptake Program Faces Setback BUYmopgcw-8/23/2005
123Thanks. JonRobohogs-8/21/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News